STOCK TITAN

Sunshine Biopharma Inc. (SBFM) Net Income by Year

SBFM

Sunshine Biopharma Inc. reported a net loss of $6.0M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $5.8M net loss. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Sunshine Biopharma Inc. has filed alongside them.

FY2025 annual
Net Income -$6.0M
YoY n/m
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SBFM Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$5.8M-$6.0Mn/m-$5.1Mn/m-$4.5Mn/m-$26.7MN/A-$2.8MN/A-$2.2Mn/m-$1.0MN/A-$1.7MN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

SBFM Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$1.6Mn/m-$1.2Mn/m-$2.1Mn/m-$884Kn/m-$1.8Mn/m-$1.2Mn/m-$2.2Mn/m-$1.2Mn/m-$494Kn/m-$1.3Mn/m-$1.3Mn/m-$651Kn/m

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Sunshine Biopharma Inc. financials

Frequently Asked Questions

What was Sunshine Biopharma Inc.'s net income in fiscal year 2025?

Sunshine Biopharma Inc. reported a net loss of $6.0M in fiscal year 2025.

How fast is Sunshine Biopharma Inc.'s net income growing?

Sunshine Biopharma Inc. (SBFM) reported a $5.1M net loss in fiscal year 2024 and a $6.0M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

What is Sunshine Biopharma Inc.'s net income over the last twelve months?

Sunshine Biopharma Inc. (SBFM) reported a $5.8M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Sunshine Biopharma Inc. (SBFM) reported -$1.6M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Sunshine Biopharma Inc. (SBFM) reported on that line in every period on record.